Roche Holding AG (RHHBY)

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Headquarters: Basel · Website: https://www.roche.com

Supply-chain relationships for RHHBY

• REGENERON PHARMACEUTICALS, INC. (REGN) — partner
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) — supplier
• GE HealthCare Technologies Inc. (GEHC) — partner
• ARVINAS, INC. (ARVN) — partner
• BIO-TECHNE Corp (TECH) — supplier
• QUEST DIAGNOSTICS INC (DGX) — supplier
• LABCORP HOLDINGS INC. (LH) — supplier
• Sysmex Corporation (6869.T) — partner
• EXELIXIS, INC. (EXEL) — partner
• ALNYLAM PHARMACEUTICALS, INC. (ALNY) — partner

Frequently asked questions about Roche Holding AG (RHHBY)

What is Roche Holding AG (RHHBY)?

Roche Holding AG (RHHBY) is a publicly traded company in the Healthcare sector (Drug Manufacturers - General). Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are Roche Holding AG's key suppliers and customers?

Macroplane tracks Roche Holding AG's (RHHBY) supply chain. Key suppliers include CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), BIO-TECHNE Corp (TECH), QUEST DIAGNOSTICS INC (DGX), LABCORP HOLDINGS INC. (LH).